{
 "drug": "Riboflavin 5-phosphate  Ophthalmic Solution",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/20/2026",
 "dayN": 217,
 "cat": "Ophthalmology",
 "companies": [
  "Glaukos Corporation"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/20/2026",
   "update_type": "New",
   "initial_posting_date": "01/20/2026",
   "package_ndc": "25357-025-03",
   "generic_name": "Riboflavin 5-phosphate  Ophthalmic Solution",
   "contact_info": "949-367-9600",
   "related_info": "Discontinuing manufacture of the product as of July 2026.",
   "openfda": {
    "application_number": [
     "NDA203324"
    ],
    "brand_name": [
     "PHOTREXA CROSS-LINKING KIT"
    ],
    "generic_name": [
     "RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC"
    ],
    "manufacturer_name": [
     "Glaukos Corporation"
    ],
    "product_ndc": [
     "25357-025"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "rxcui": [
     "1925825",
     "1925830"
    ],
    "spl_id": [
     "c945d9a7-2e14-41c7-a209-e537aba21749"
    ],
    "spl_set_id": [
     "f82cfe92-1a24-11e3-8ffd-0800200c9a66"
    ],
    "package_ndc": [
     "25357-025-03"
    ]
   },
   "update_date": "01/20/2026",
   "therapeutic_category": [
    "Ophthalmology"
   ],
   "dosage_form": "Ophthalmic Solution",
   "presentation": "Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)",
   "company_name": "Glaukos Corporation",
   "status": "To Be Discontinued"
  }
 ]
}